Ffcd

Ffcd company information, Employees & Contact Information

Explore related pages

Related company profiles:

La Fédération Francophone de Cancérologie digestive est constituée d’un réseau national de médecins, cliniciens et chercheurs experts en cancérologie digestive. Ses objectifs majeurs sont : • la coordination d’essais thérapeutiques • la formation des professionnels de santé en oncologie digestive Le portefeuille d’études de la FFCD est aujourd’hui le plus important dans le domaine de la cancérologie digestive française, permettant ainsi à chaque patient qui le souhaite d’accéder aux programmes de recherche encadrés par les spécialistes de la profession. #rechercheclinique #oncologiedigestive #cancerologie

Company Details

Employees
32
Founded
-
Address
7, Boulevard Jeanne D'arc, Dijon,bourgogne-Franche-Comté 21000,france
Industry
Think Tanks
NAICS
Research and Development in the Social Sciences and Humanities
Website
ffcd.fr
Keywords
Paris.
HQ
Dijon, Bourgogne-Franche-Comté
Looking for a particular Ffcd employee's phone or email?

Ffcd Questions

News

10 Must-Read Posts in GI Oncology This Week - Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings - Nature

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings Nature

Tibial deformities caused by focal fibrocartilaginous dysplasia: a narrative review - Frontiers

Tibial deformities caused by focal fibrocartilaginous dysplasia: a narrative review Frontiers

Gov. Hochul suggests 'slow down' on NYS climate law given concerns on utility rates for consumers - WGRZ

Gov. Hochul suggests 'slow down' on NYS climate law given concerns on utility rates for consumers WGRZ

Modified FLOT Beats FOLFOX for Advanced Gastric Cancer - MedPage Today

Modified FLOT Beats FOLFOX for Advanced Gastric Cancer MedPage Today

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial - ASCO Publications

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial ASCO Publications

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial - The Lancet

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial The Lancet

Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) - ScienceDirect.com

Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) ScienceDirect.com

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 - ASCO Publications

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 ASCO Publications

Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE - Nature

Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE Nature

Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts - The Lancet

Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts The Lancet

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial - Nature

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial Nature

Fashion for charity event - dailynews.co.za

Fashion for charity event dailynews.co.za

Top Ffcd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant